Quality of life and emotional impact of a fixed-dose combination of antihypertensive drugs in patients with uncontrolled hypertension

被引:9
|
作者
Schmieder, Roland E. [1 ]
Jumar, Agnes [1 ]
Fronk, Eva-Maria [2 ]
Alexandre, Ana-Filipa [2 ]
Bramlage, Peter [3 ]
机构
[1] Univ Hosp Erlangen, Dept Nephrol & Hypertens, Erlangen, Germany
[2] Daiichi Sankyo Europe GmbH, Munich, Germany
[3] Inst Pharmacol & Prevent Med, Mahlow, Germany
来源
JOURNAL OF CLINICAL HYPERTENSION | 2017年 / 19卷 / 02期
关键词
blood pressure control; fixed-dose combination therapy; hypertension; mental health; quality of life; TREATMENT-RESISTANT HYPERTENSION; BLOOD-PRESSURE; MANAGEMENT; OLMESARTAN; AMLODIPINE; KNOWLEDGE; ATTITUDES; AWARENESS;
D O I
10.1111/jch.12936
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Often considered to be a symptomless condition, hypertension can be associated with a significant emotional burden. To analyze changes of health-related quality of life as well as the emotional burden questions regarding the impact of hypertension were incorporated into the noninterventional SeviTarget study. Comparisons were made between baseline and follow-up findings, and between patients with treatment target achievement and those without. A total of 5831 patients were recruited. At baseline, only 33.3% of patients described their current state of health as good or excellent, while at follow-up this value had risen to 75.8%. Responses regarding symptoms and limitations in activities and mental factors such as anxiety associated with treatment all improved during antihypertensive treatment. Changes to more optimistic responses were more likely for patients who achieved a target BP of <140/90mm Hg. The study demonstrates that improvements in quality of life and the perceived emotional burden related to hypertension can be achieved with effective management of hypertension.
引用
收藏
页码:126 / 134
页数:9
相关论文
共 50 条
  • [41] EXPLORING THE RELATIONSHIP OF COST SHARING AND FIXED-DOSE COMBINATION VERSUS MONO ANTIHYPERTENSIVE MEDICATION THERAPY AMONG HYPERTENSION PATIENTS
    Tang, J.
    VALUE IN HEALTH, 2010, 13 (03) : A160 - A160
  • [42] Use of Fixed-Dose Combination Drugs for the Treatment of Glaucoma
    Albert S. Khouri
    Tony Realini
    Robert D. Fechtner
    Drugs & Aging, 2007, 24 : 1007 - 1016
  • [43] Shortage of Fixed-Dose Combination of Antituberculous Drugs in Spain
    Garcia-Garcia, Jose-Maria
    Rodrigo Sanz, Teresa
    Quiros Fernandez, Sarai
    de la Rosa Carrillo, David
    ARCHIVOS DE BRONCONEUMOLOGIA, 2020, 56 (02): : 118 - 119
  • [44] Use of fixed-dose combination drugs for the treatment of glaucoma
    Khouri, Albert S.
    Realini, Tony
    Fechtner, Robert D.
    DRUGS & AGING, 2007, 24 (12) : 1007 - 1016
  • [45] Nebivolol/valsartan: Fixed-dose combination for treatment of hypertension
    Paton, D. M.
    DRUGS OF TODAY, 2017, 53 (01) : 19 - 26
  • [46] Nebivolol and valsartan as a fixed-dose combination for the treatment of hypertension
    Sander, Gary E.
    Giles, Thomas D.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (05) : 763 - 770
  • [47] Amlodipine/Valsartan/Hydrochlorothiazide Fixed-Dose Combination in Hypertension
    Deeks, Emma D.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2009, 9 (06) : 411 - 418
  • [48] Impact of fixed-dose combination of perindopril/amlodipine on left ventricular myocardial deformation in patients with arterial hypertension
    Kolesnyk, M. Y.
    Dzyak, G. V.
    Didenko, Y. V.
    EUROPEAN HEART JOURNAL, 2015, 36 : 323 - 324
  • [49] Efficacy and safety of olmesartan medoxomil/amlodipine fixed-dose combination for hypertensive patients uncontrolled with monotherapy
    Zhu, Jun-Ren
    Zhang, Shu-Yang
    Gao, Ping-Jin
    ARCHIVES OF PHARMACAL RESEARCH, 2014, 37 (12) : 1588 - 1598
  • [50] A Fixed-Dose Combination of Bisoprolol and Amlodipine for Hypertension: A Potential Benefit to Selected Patients
    Cohen, Brian J.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (01): : 6 - 8